Inside CMS - 01/11/2018

House E&C Releases Recommendations To Revamp 340B

January 10, 2018
The House Energy & Commerce Committee released a report Wednesday (Jan. 10) with several recommended changes to the 340B drug discount program -- including giving the Health Resources and Services Administration more authority, resources and staff; requiring more audits of manufacturers and providers; and clarifying the intent of the 340B program. "Congress did not clearly identify the intent of the program and did not identify clear parameters, leaving the statute silent on many important program requirements," the report says, noting...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.